Panel & Audience Discussion: Supercharging Antigen-Specific Approaches to Autoimmune Disease Patients: Evaluating the Next Steps to Move Forward as a Field

Time: 3:45 pm
day: Conference Day Two


  • Selecting antigens – what makes a ‘good’ antigen?
  • Assessing preclinical models – what should we move towards for regulatory buy-in?
  • Creating a biomarker toolbox – what biomarkers could be a tolerance endpoint?
  • Honing clinical study design – what are key considerations for tolerance?